Lendlease-Warburg Pincus life sciences and R&D joint venture unveils its brand identity — Vita Partners

‍

Singapore, February 10, 2025 –The life sciences and R&D joint venture formed by Lendlease and Warburg Pincus has unveiled its official name and brand identity as Vita Partners. Backed by two industry leaders with established track records and sector expertise, Vita Partners is uniquely positioned to combine a specialized investment management business supported by sophisticated institutional investors and a high barrier-to-entry life sciences project and construction management business. Headquartered in Singapore, Vita Partners is the leading integrated platform in Asia-Pacific that develops, constructs, manages and invests in life sciences, R&D and innovation real estate.

‍

The global life sciences and R&D sector is expanding, with Asia-Pacific poised for accelerated growth. This creates significant and unique opportunities for life sciences and R&D real estate, underpinned by multiple tailwinds such as the continued rise of innovation and technology, demographic shifts, increasing healthcare demand, supply chain realignments, and sustained government support. In Asia-Pacific, the life sciences and R&D sector remained resilient throughout the cycle with continued investment from both investment-grade companies and governments.

‍

With over S$2 billion of assets under management, comprising R&D and innovation facilities, logistics, laboratories, manufacturing, and business parks across key Asia-Pacific markets, VitaPartners offers a fully integrated platform to capitalize on the attractive opportunities in the sector and deliver outsized returns to its investment partners. As the market leader in the life sciences and R&D sector in Asia-Pacific and having delivered more than 200 projects for pharmaceutical clients worldwide (through its prior history with Lendlease), Vita Partners, with a team of over 240 professionals, provides a full suite of real estate solutions, including state-of-the-art facilities built by our project and construction management business as well as the leased facilities under the management of Vita’s investment management business.

‍

Since his appointment as Chief Executive Officer in January, Bart Price has been overseeing the platform’s strategic growth plans. He is supported by a team of seasoned real estate and investment specialists who actively manage Vita Partners’ life science and R&D assets, sourced through an extensive network of relationships. Vita Partners’ investment strategy is focused on asset enhancement through value-add initiatives, development, and asset recycling strategies to optimize returns for investors and partners. The project and construction management business remains core to Vita Partners’ strategic objectives, providing ready access to a global client network through its market leadership position.

‍

Bart Price, CEO of Vita Partners, said, “Vita Partners is a unique and differentiated platform in the life sciences and R&D sector in Asia-Pacific with deep capabilities, track record, and relationships built over 20 years, through our history with Lendlease.

‍

"We chose the name ‘Vita,’ which means ‘life’ in Latin, to embody the core of our business: creating and supporting opportunities that enhance lives. In the life sciences space, our clients develop groundbreaking products to improve health outcomes. In the R&D space, they drive innovation through technological advancements that positively impact lives. For our institutional investment partners, we help grow savings and pensions to secure financial futures. In addition, sustainability and safety are core to our business philosophy, and we are dedicated to providing solutions that meet the real estate and investment needs of our clients.

‍

"With 20 years of proven expertise, Vita Partners combines deep industry knowledge with innovative strategies, positioning itself as the go-to platform for Asia-Pacific’s rapidly growing life sciences and R&D real estate sector. Our commitment to innovation, safety, sustainability, and client success ensures we stay ahead in meeting the evolving needs of this dynamic industry and providing our investors with opportunities to capture outsized returns from investment in real estate.”

‍

Established in July 2024, Vita Partners is a joint venture between Warburg Pincus, a pioneer of global growth investing, and Lendlease, a market-leading Australian integrated real estate group. The platform, alongside its managed investment vehicle LINO, acquired a ~S$1.6b portfolio of assets in Singapore in August 2024, marking one of the largest private portfolio transactions for industrial assets in the country.  

About Vita Partners

Vita Partners is the market-leading, pan-Asia Pacific integrated life sciences, R&D, and innovation real assets platform that develops, constructs, manages and invests in high-quality real estate to cater to the evolving needs of these industries. Established by Lendlease and Warburg Pincus, Vita Partners offers a full suite of life science and R&D solutions, including specialized investment management and asset management backed by sophisticated institutional investors, and best-in-class project and construction management services. With a proven track record of achieving outsized returns, Vita Partners has over S$2 billion in assets under management, having delivered more than 200 projects for over 100 life sciences companies worldwide. For more information, visit www.vitapartners.com

‍

Media Contacts

H/Advisors Klareco

Klareco-Lendlease@h-advisors.global

‍